Robert L. Buchanan

Robert L. Buchanan is a seasoned professional in the life sciences and biotechnology sectors, currently serving as co-founder and board member for RORA Biologics and Ambulero since 2021 and 2019 respectively. At the University of Miami, Buchanan acts as Entrepreneur In Residence and is a member of the Oversight Committee at the Wallace H. Coulter Center for Translational Research. With extensive experience in intellectual property as Associate General Counsel at Biogen and General Counsel at Avexxin AS, Buchanan co-founded Regenesance BV and Idogen AB, contributing significantly to the development of innovative therapeutic solutions. Buchanan's educational background includes a Ph.D. in Biochemistry from UCLA, a Juris Doctor from Suffolk University Law School, and a BS in Biochemistry from the University of Massachusetts Amherst.